期刊文献+

精神分裂症患者认知功能与临床特征关系分析 被引量:6

下载PDF
导出
摘要 目的探讨精神分裂症患者认知功能与临床特征的关系。方法采用事件相关电位(Event-related Potentials,ERP)P300和探究性眼动分析(exploratory eye movement,EEM)评估患者组及对照组的认知功能,同时采用阳性和阴性症状量表(PANSS)评定患者的精神症状。结果患者组P300潜伏期较对照组延长,波幅降低,EEM中NEF及RSS减少,D值增加,差异均具有统计学意义(P<0.01)。患者组P300潜伏期与PANSS量表一般状况分、思维障碍评分及激活性评分均呈负相关(P<0.05),波幅与PANSS量表阴性症状分及一般状况分均呈负相关(P<0.01,P<0.05);EEM中凝视点数(NEF)与阴性症状分呈负相关(P<0.05),PANSS总分与反应性探索评分(RSS)呈负相关(P<0.05),与D值呈正相关(P<0.01)。结论 P300和EEM测定可作为精神分裂症认知功能诊断的参考指标之一;阴性症状的严重程度是影响精神分裂症患者认知功能的主要因素。
出处 《中国实用神经疾病杂志》 2016年第10期59-60,共2页 Chinese Journal of Practical Nervous Diseases
  • 相关文献

参考文献10

  • 1Javitt DC, Sweet RA. Auditory dysfunction in schizophrenia: integrating clinical and basic features[J]. Nat Rev Neurosci, 2015,16(9):535-550.
  • 2Agarwal SM, Danivas V, Amaresha AC, et al. Cognitive map- ping deficits in schizophrenia: Evidence from clinical correlatesof visuospatial transformations [J]. Psychiatry Res, 2015,228 (3) :304-311.
  • 3Ozgiirdal S,Gudlowski Y,Witthaus H, et al. Reduction of au- ditory event related P300 amplitude in subjects with at risk mental state for schizophrenia [J]. Schizophrenia Research, 2008, 105(1/2): 272-278.
  • 4Frangou S. Cognitive function in early onset schizophrenia: a selective review[J]. Front Hum Neurosci ,2010, 29(3) :79.
  • 5Ikeda C, Kirino E, Inoue R, et al. Event-related potential study of illusory contour perception in schizophrenia[J]. Neu- ropsychobiology, 2011, 64(4) : 231-238.
  • 6Lencer R, Keedy SK, Reilly JL, et al. Altered transfer of vis- ual motion information to parietal association cortex in un- treated first-episode psychosis: implications for pursuit eye tracking[J]. Psychiatry Res, 2011, 194(1) :30-38.
  • 7Bilder RM, Howe A, Novak N,et al. The genetics of cogni- tive impairment in schizophrenia: a phenomic perspective[J]. Trends Cogn Sci,2011,15(9) :428-435.
  • 8杨可冰,陈大春,张向阳,李艳丽,王宁,聂鹰.利培酮治疗对首发精神分裂症认知功能的影响[J].中国健康心理学杂志,2010,18(8):897-900. 被引量:9
  • 9Bralet MC, Navarre M, Eskenazi AM, et al. FInterest of a- new instrument to assess cognition in schizophrenia : TheBrief Assessment of Cognition in Schizophrenia (BACS): [J]. En- eephale, 2008,34(6) :557-562.
  • 10Cullen K, Guimaraes A, Wozniak J, et al. Trajectories ofsocial withdrawal and cognitive decline in the sehizophreniaprodrome [J]. Clin Schizophr Relat Psychoses, 2011,4(4) .-229-238.

二级参考文献16

  • 1Meltzer H Y, McGurk S R. The effects of clozapine, risperidone. and olanzapine on cognitive function in schizophrenia[J]. Schizophr Bull, 1999,25 (2) 233-255.
  • 2Young J W, Powell S B. Risbrough Vet al. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia[J]. Pharmacol Ther, 2009,122 (2) : 150-202.
  • 3Stip E. Cognition, schizophrenia and the effect of antipsycholics[J]. Encephale,2006,32(3 Pt 1) :341-350.
  • 4Jeffrey, Lieberman, Michael Phillips. et al. Atypical and conven tional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine[J]. Neuropsychopharmacology, 2003,28:995-1003.
  • 5Mary P, Richard Goldberg, John J,et al. Repeatable battery for the assessment of neuropsychologieal status as a screening test in schizophrenia, II: convergent/discriminam validity and diagnostic group comparisons[J]. Am J Psychiatry, 1999,156 . 1951-1957.
  • 6Gold J M, Queern C, Iannone V N,et al. Repeatable battery for the assessment of neuropsyebological status as a screening test in schizophrenia I: sensitivity, reliability, and validity[J].Am J Psychiatry, 1999,156:1944-1950.
  • 7Christopher M, James M, John J. Test-retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia[J].Am J Psychiatry, 2002,159 : 838-844.
  • 8Palmer B W,Dawes S E,Heaton R K. What do we know about neu- ropsychological aspects of schizophrenia [J ]. Neuropsychol Rev. 2009,19(3) :365-384.
  • 9Bralet M C,Navarre M,Eskenazi A M,et al. Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)[J].Encephale, 2008. 34(6) :557-562.
  • 10Harvey P D,Rabinowitz J, Eerdekens M,et al. Treatment o:f cognitive impairment in early psychosis. a comparison of risperidone and haloperidol in a large long-term trial[J].Am J Psychiatry. 2005,162(10) : 1888-1895.

共引文献8

同被引文献70

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部